Mirae Asset Global Investments Co., Ltd. Precigen, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Precigen, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,536 shares of PGEN stock, worth $7,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,536Holding current value
$7,912% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
143Shares Held
144MCall Options Held
292KPut Options Held
53.8K-
Third Security, LLC83.5MShares$87.6 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD18.2MShares$19.1 Million1.57% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.76MShares$7.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.1MShares$3.25 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $219M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...